APOE and Alzheimer disease: Preclinical individuals with higher Alzheimer’s disease risk based on biomarkers or the APOE genotype have been reported to show poorer performance in mnemonic discrimination (combined group of heterozygotes and homozygotes) and continuous report tasks of feature binding in long-term memory (homozygotes).29